| scholarly article | Q13442814 |
| P50 | author | Kaylon L. Bruner-Tran | Q91327995 |
| Kevin G. Osteen | Q91328000 | ||
| P2093 | author name string | Esther Eisenberg | |
| Grant R Yeaman | |||
| Judith McBean | |||
| Ted A Anderson | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endometriosis | Q205764 |
| P304 | page(s) | 4782-4791 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice | |
| P478 | volume | 87 |
| Q21245557 | A baboon model for endometriosis: implications for fertility |
| Q34337117 | A novel role of the Sp/KLF transcription factor KLF11 in arresting progression of endometriosis |
| Q33994540 | Aberrant gene expression profile in a mouse model of endometriosis mirrors that observed in women |
| Q38298585 | Abundance and Localization of Progesterone Receptor Isoforms in Endometrium in Women With and Without Endometriosis and in Peritoneal and Ovarian Endometriotic Implants |
| Q44815007 | An improved mouse model for endometriosis allows noninvasive assessment of lesion implantation and development. |
| Q33518252 | Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis |
| Q36268501 | Comparison of c-DNA microarray analysis of gene expression between eutopic endometrium and ectopic endometrium (endometriosis) |
| Q38446659 | Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease |
| Q40243432 | Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer |
| Q37061095 | Deficiency of immunophilin FKBP52 promotes endometriosis |
| Q35828047 | Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis |
| Q37448466 | Different effects of the immunomodulatory drug GMDP immobilized onto aminopropyl modified and unmodified mesoporous silica nanoparticles upon peritoneal macrophages of women with endometriosis. |
| Q33874669 | Dioxin and endometrial progesterone resistance |
| Q34010947 | Dioxin may promote inflammation-related development of endometriosis |
| Q33714778 | EMMPRIN is secreted by human uterine epithelial cells in microvesicles and stimulates metalloproteinase production by human uterine fibroblast cells |
| Q47960296 | Early Endometriosis in Females Is Directed by Immune-Mediated Estrogen Receptor α and IL-6 Cross-Talk |
| Q36663065 | Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis |
| Q36855660 | Endometrial-peritoneal interactions during endometriotic lesion establishment |
| Q37143821 | Endometriosis is associated with progesterone resistance in the baboon (Papio anubis) oviduct: evidence based on the localization of oviductal glycoprotein 1 (OVGP1). |
| Q51800091 | Endometriotic epithelial cells induce MMPs expression in endometrial stromal cells via an NFkappaB-dependent pathway. |
| Q52882350 | Epigenetic Modulation of Collagen 1A1: Therapeutic Implications in Fibrosis and Endometriosis. |
| Q73399938 | Estrous changes in vaginal nociception in a rat model of endometriosis |
| Q80796617 | Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2 |
| Q33862747 | Experimental endometriosis in immunocompromised mice after adoptive transfer of human leukocytes |
| Q33583671 | Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium |
| Q37349676 | Extracellular matrix metalloproteinase inducer expression in the baboon endometrium: menstrual cycle and endometriosis |
| Q53171362 | IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis. |
| Q35486220 | Immune interactions in endometriosis |
| Q37361813 | Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis |
| Q37727545 | Inhibition of macrophage migration inhibitory factor reduces endometriotic implant size in mice with experimentally induced disease |
| Q36971539 | Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis. |
| Q92932851 | Matrix metallopeptidase expression and modulation by transforming growth factor-β1 in equine endometrosis |
| Q55223594 | Matrix remodeling and endometriosis. |
| Q37032251 | Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology |
| Q51068219 | Melatonin causes regression of endometriotic implants in rats by modulating angiogenesis, tissue levels of antioxidants and matrix metalloproteinases. |
| Q54617825 | Menstrual effluent in endometriosis shows no difference in volume, VEGF-A, MMP2 and MMP9 or sFLT. |
| Q53350449 | Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study. |
| Q35946114 | Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis. |
| Q35903625 | Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease |
| Q36875771 | Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. |
| Q33714186 | Novel therapies targeting endometriosis |
| Q36964196 | PAI-1 secretion of endometrial and endometriotic cells is Smad2/3- and ERK1/2-dependent and influences cell adhesion |
| Q24596679 | Pathogenesis and pathophysiology of endometriosis |
| Q28083420 | Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways |
| Q38546195 | Pathogenetic Mechanisms of Deep Infiltrating Endometriosis |
| Q56981657 | Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis |
| Q34147704 | Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer |
| Q39250801 | Progesterone resistance in endometriosis: origins, consequences and interventions |
| Q36291274 | Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). |
| Q43293881 | Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model |
| Q44848772 | Quantitative assessment of human endometriotic tissue maintenance and regression in a noninvasive mouse model of endometriosis |
| Q35617470 | Retinoic acid biosynthesis is impaired in human and murine endometriosis. |
| Q36007557 | Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis |
| Q54962618 | Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets. |
| Q36114008 | Role of estrogen receptor signaling required for endometriosis-like lesion establishment in a mouse model |
| Q36121605 | Simvastatin decreases invasiveness of human endometrial stromal cells |
| Q37257551 | Simvastatin protects against the development of endometriosis in a nude mouse model |
| Q54481388 | Survivin, MMP-2, MT1-MMP, and TIMP-2: their impact on survival, implantation, and proliferation of endometriotic tissues. |
| Q37452210 | The M2 polarization of macrophage induced by fractalkine in the endometriotic milieu enhances invasiveness of endometrial stromal cells |
| Q33751926 | The Role of Endocrine Disruptors in the Epigenetics of Reproductive Disease and Dysfunction: Potential Relevance to Humans |
| Q90683993 | The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review) |
| Q37348033 | The non-human primate model of endometriosis: research and implications for fecundity |
| Q24564121 | The role of lipoxin A4 in endometrial biology and endometriosis |
| Q37436820 | The role of matrix metalloproteinases in the pathogenesis of endometriosis |
| Q26998559 | The role of the peritoneum in the pathogenesis of endometriosis |
| Q38891615 | Therapeutically Targeting the Inflammasome Product in a Chimeric Model of Endometriosis-Related Surgical Adhesions |
| Q36069879 | Transforming growth factor β1 (TGFβ1) and progesterone regulate matrix metalloproteinases (MMP) in human endometrial stromal cells |
| Q37460606 | Uterine glands impact uterine receptivity, luminal fluid homeostasis and blastocyst implantation |
| Q58122541 | Weighted Gene Co-expression Network Analysis of Endometriosis and Identification of Functional Modules Associated With Its Main Hallmarks |
| Q47331462 | Xenografted tissue models for the study of human endometrial biology |
Search more.